5 unknown, 4 recruiting, 3 completed, 1 not yet recruiting. 3 Phase 2, 2 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 2, Completed 1 |
| Not applicable | 2 | Completed 1, Unknown 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Anti-N-Methyl-D-Aspartate Receptor Encephalitis: new trials by email Literature Review of Anti-N-Methyl-D-Aspartate Receptor Encephalitis trials Research Report on Anti-N-Methyl-D-Aspartate Receptor Encephalitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Evaluation of a Novel DAB Chromogenic Tissue-Based Assay for Detecting Anti-GABABR Antibodies Autoimmune Encephalitis, Anti-NMDAR Encephalitis | Not yet recruiting | Third Affiliated Hospital, Sun Yat-Sen University | 300 | 2026-10-01 | 2026-10-05 | |
| Efgartigimod in Anti-NMDA Receptor Encephalitis. Efgartigimod Alfa - Encephalitis Autoimmune | Phase 2 | Recruiting | Beijing Tongren Hospital | 20 | 2026-06-25 | 2026-09-16 |
| Efficacy and Safety of Taitacept in Treatment of Refractory or Recurrent Anti-NMDAR/anti-LGI1 Encephalitis Taitacept - Anti-N-Methyl-D-Aspartate Receptor Encephalitis | Phase 2 | Recruiting | Beijing Tongren Hospital | 10 | 2024-12-01 | 2024-11-20 |
| Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis Ofatumumab combined with daratumumab, Ofatumumab, Repeated intravenous immunoglobulin/plasma exchange therapy - Anti-N-Methyl-D-Aspartate Receptor Encephalitis | Phase 3 | Recruiting | The First People's Hospital of Changzhou | 200 | 2024-11-08 | 2026-06-09 |
| A Case Report of NMDAR Encephalopathy Magnetic Resonance Imaging (MRI), Salpingo-oophorectomy - Anti-NMDA Receptor Encephalitis, Mature Teratoma | Completed | Mayo Clinic | 1 | 2024-06-20 | 2025-04-08 | |
| Antibody-mediated NMDA Receptor Encephalitis: Symptoms, Biomarkers, and Mechanisms of the Prolonged Recovery Stage Remote cognitive rehabilitation program - Anti-NMDA Receptor Encephalitis | Not applicable | Unknown | Fundacion Clinic per a la Recerca Biomédica | 20 | 2023-01-16 | 2024-05-06 |
| Developing Advanced Neuroimaging for Clinical Evaluation of Autoimmune Encephalitis Not applicable - non-interventional study - Anti-N-Methyl-D-Aspartate Receptor Encephalitis, Autoimmune Encephalitis | Unknown | King's College London | 75 | 2022-05-19 | 2023-10-06 | |
| Clinical-immunological Features of Anti-NMDAR Encephalitis Description of clinical characteristic - Anti NMDA Receptor Encephalitis | Unknown | Hospices Civils de Lyon | 400 | 2022-02-01 | 2023-02-22 | |
| Immunoadsorption Therapy in Managing NMDAR Antibodies Encephalitis IA session, Rituximab - Anti-NMDAR Encephalitis | Phase 2 | Completed | Assistance Publique - Hôpitaux de Paris | 20 | 2021-06-23 | 2026-08-10 |
| Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD) Optic Neuritis, Transverse Myelitis | Recruiting | University of Bern | 500 | 2020-04-14 | 2024-12-16 | |
| Autoimmune Encephalitis With Anti-NMDA Receptor Antibodies Following Herpetic Encephalitis Description and analysis - Autoimmune Encephalitis, Anti NMDA Receptor Encephalitis | Unknown | Hospices Civils de Lyon | 12 | 2020-04-01 | 2020-04-09 | |
| Multicenter and Prospective Clinical Registry Study of Anti-N-methyl-D-aspartate Receptor Encephalitis in Beijing Area Anti-N-Methyl-D-Aspartate Receptor Encephalitis | Unknown | Jia Wei Wang,MD | 400 | 2014-06-01 | 2015-05-13 | |
| Transcranial Direct Current Stimulation on Cortical Plasticity in Patients With Anti-NMDA Receptor Encephalitis tDCS, Sham Stimulation - Anti-NMDA Receptor Encephalitis | Not applicable | Completed | Charite University, Berlin, Germany | 40 | 2012-04-01 | 2016-03-17 |
Autoimmune Diseases of the Nervous System (6) · Encephalitis (2) · Cognitive Dysfunction (1) · Dermoid Cyst (1) · Encephalitis, Herpes Simplex (1) · Encephalomyelitis, Acute Disseminated (1) · Lupus Vasculitis, Central Nervous System (1) · Multiple Sclerosis (1) · Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (1) · Myelitis, Transverse (1) · Neuromyelitis Optica (1) · Optic Neuritis (1) · Paraneoplastic Syndromes (1) · Recurrence (1)
Autoimmune Diseases (13) · Brain Diseases (13) · Central Nervous System Diseases (13) · Immune System Diseases (13) · Neoplasms (13) · Neoplasms by Site (13) · Nervous System Diseases (13) · Nervous System Neoplasms (13) · Neurodegenerative Diseases (13) · Neuroinflammatory Diseases (13) · Paraneoplastic Syndromes, Nervous System (13) · Paraneoplastic Syndromes (12) · Encephalitis (11) · Autoimmune Diseases of the Nervous System (7) · Central Nervous System Infections (2)
Magnetic Resonance Imaging (1) · Rituximab (1) · Salpingo-oophorectomy (1) · Transcranial Direct Current Stimulation (1) · daratumumab (1) · efgartigimod alfa (1) · ofatumumab (1)
Beijing Tongren Hospital (2) · Hospices Civils de Lyon (2) · Assistance Publique - Hôpitaux de Paris (1) · Charite University, Berlin, Germany (1) · Fundacion Clinic per a la Recerca Biomédica (1) · Jia Wei Wang,MD (1) · King's College London (1) · Mayo Clinic (1) · The First People's Hospital of Changzhou (1) · Third Affiliated Hospital, Sun Yat-Sen University (1) · University of Bern (1)
China (5) · France (3) · Germany (1) · Spain (1) · Switzerland (1) · United Kingdom (1) · United States (1)
Agnes Floeel, Prof. MD (1) · David W Carmichael, PhD MSci (1) · Jiawei Wang (1) · Josep Dalmau, MD, PhD (1) · Sandra Bigi, PD MD (1) · Tri A. Dinh, MD (1) · Wei Qiu, MD (1)
PMID 26900584, PMID 32759178, PMID 42293080
2019 (1)